Article Information
History
- November 10, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Nasamon Wanlapakorna,#,
- Sitthichai Kanokudoma,b,#,
- Harit Phowatthanasathianc,
- Jira Chansaenroja,
- Nungruthai Suntronwonga,
- Suvichada Assawakosria,b,
- Ritthideach Yorsaenga,
- Pornjarim Nilyanimita,
- Preeyaporn Vichaiwattanaa,
- Sirapa Klinfuenga,
- Thanunrat Thongmeea,
- Ratchadawan Aeemjindaa,
- Nongkanok Khanarata,
- Donchida Srimuana,
- Thaksaporn Thatsanatorna,
- Natthinee Sudhinaraseta and
- Yong Poovorawana,d,*
- aCenter of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, 10330, Thailand
- bCenter of Excellence in Osteoarthritis and Musculoskeleton, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, 10330, Thailand
- cChulalongkorn University International Medical Program (CU-MEDi), Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
- dFRS(T), the Royal Society of Thailand, Sanam Sueapa, Dusit, Bangkok, 10300, Thailand
- ↵*Corresponding authors: Yong Poovorawan (yong.p{at}chula.ac.th).
↵# These two authors equally contribute to the study.
Posted November 10, 2022.
Comparison of the reactogenicity and immunogenicity between two-dose mRNA COVID-19 vaccine and inactivated followed by an mRNA vaccine in children aged 5 - 11 years
